Xenotransplantation Clinical Advancement Market

In 2026, kidney transplantation accounts for 42.2% of the xenotransplantation clinical advancement market by organ type. The largest clinical stage share, 44.2%, belongs to preclinical studies; the application category is led by end-stage organ failure with 31.3%.